Paras Healthcare Limited is preparing to launch its initial public offering on October 21, 2026, drawing attention from market participants tracking hospital chains expanding into tier 2 and tier 3 cities. Established in 1987, the company operates under the Paras Health brand and ranks as the fifth-largest healthcare provider across North India, Bihar, and Jharkhand. With the issue scheduled to close on October 23, 2026, investors are closely examining the structure, timelines, and unofficial market sentiments surrounding the offering.
Paras Healthcare IPO Schedule and Issue Structure
The book-built issue aims to raise approximately ₹1,450 crores in total. The offering comprises a fresh issue of approximately ₹500 crores alongside an offer for sale of approximately ₹950 crores. Equity shares carry a face value of ₹1 per share, while the exact price band remains to be finalized in the prospectus filed with exchanges.
The bidding timeline begins on October 21, 2026, and concludes on October 23, 2026. Following the close of bidding, the registrar will finalize the basis of allotment on October 26, 2026. Refunds and the credit of shares to demat accounts are scheduled for October 27, 2026, leading up to the anticipated stock exchange listing on October 28, 2026, on both the National Stock Exchange and the Bombay Stock Exchange.
| IPO Parameter | Details |
|---|---|
| IPO Open Date | October 21, 2026 |
| IPO Close Date | October 23, 2026 |
| Total Issue Size | Approx ₹1,450 Crores |
| Fresh Issue | Approx ₹500 Crores |
| Offer for Sale | Approx ₹950 Crores |
| Face Value | ₹1 Per Equity Share |
| Listing Exchanges | NSE, BSE |
Company Background and Operational Footprint
Paras Healthcare operates 8 hospitals across North India, serving regions in Haryana, Bihar, Uttar Pradesh, Rajasthan, Jharkhand, and Jammu and Kashmir. Key operational hubs include Gurugram and Patna. The organization focuses on delivering medical services in underserved tier 2 and tier 3 urban centers. Its medical portfolio spans multiple specialized departments, including heart care, oncology, neurology, gastroenterology, and orthopedic joint replacements.
Operational scale has scaled upward over recent years. Between March 2022 and March 2024, total bed capacity expanded from 1,250 beds to 2,135 beds. To support this hospital network, the company maintained a professional workforce comprising 1,091 doctors and 1,509 nurses as of March 31, 2024.
Unofficial Grey Market Premium and Market Sentiment
The grey market functions as an unofficial, unregulated venue where market participants gauge preliminary demand before formal listing. Recent activity shows fluctuations in the unofficial premium. On October 14, the reported premium stood at ₹50, before advancing to a high of ₹115 on October 15. Subsequently, the unofficial indicator adjusted to ₹90 on October 16.
| Date | IPO GMP | GMP Trend | Calculated Indication |
|---|---|---|---|
| 16 October | ₹90 | 🔴 Downward | 12.99% |
| 15 October | ₹115 | 🟢 Upward | 16.59% |
| 14 October | ₹75 | 🟢 Upward | -% |
Market and Business Analysis
Market Impact and Investor Sentiment
The public offering arrives during a period of sustained investor appetite for specialized healthcare infrastructure providers in India. The deliberate strategic focus on tier 2 and tier 3 cities sets Paras Healthcare apart from peers concentrated exclusively in metropolitan centers. This positioning captures rising regional demand for advanced secondary and tertiary care. The unofficial grey market premium, touching a peak of ₹115, reflects positive initial engagement from early-stage market participants. However, market observers emphasize that unofficial premiums remain volatile and can shift rapidly based on broader market liquidity and upcoming macroeconomic disclosures.
Company Growth and Scalability
The expansion of bed capacity from 1,250 to 2,135 beds over a two-year window demonstrates strong operational scalability. This capital expenditure supports revenue growth by accommodating higher patient volumes across core facilities like Gurugram and Patna. The deployment of the fresh issue proceeds of approximately ₹500 crores is expected to provide additional capital for network expansion, reducing reliance on debt financing for future hospital builds. Maintaining a clinical team of 1,091 doctors and 1,509 nurses underscores the organization’s ability to attract medical talent to support multi-specialty departments such as oncology and neurology.
Valuation and Financial Context
With an aggregate issue size of approximately ₹1,450 crores split between a ₹500 crore fresh issue and a ₹950 crore offer for sale, existing promoters and early investors are partially monetizing their holdings while injecting growth capital into the balance sheet. While specific bottom-line earnings multiples will become transparent once the final price band is announced, the sizeable offer for sale indicates substantial historical value creation since the enterprise was founded in 1987. The balance between fresh capital generation and promoter dilution provides a structural checkpoint for institutional analysts assessing capital allocation efficiency.
Paras Healthcare IPO Opens October 21: Issue Details, Financials and Peer Comparison offers additional perspective on how this offering stacks up against sector competitors in the domestic market.
Key Takeaways
- Paras Healthcare IPO opens on October 21, 2026, and closes on October 23, 2026.
- The total issue size is approximately ₹1,450 crores, consisting of a ₹500 crore fresh issue and a ₹950 crore offer for sale.
- The company operates 8 regional hospitals with a total capacity of 2,135 beds supported by 1,091 doctors.
- The unofficial grey market premium reached a high of ₹115 before settling around ₹90 on October 16.
- Shares are scheduled to list on the NSE and BSE on October 28, 2026, following share allotment on October 26, 2026.
Frequently Asked Questions
The IPO opens on October 21, 2026, and closes on October 23, 2026.
The total issue size is approximately ₹1,450 crores.
The issue includes a fresh issue of approximately ₹500 crores and an offer for sale of approximately ₹950 crores.
The basis of allotment is scheduled to be finalized on October 26, 2026.
The shares are scheduled to list on the NSE and BSE on October 28, 2026.
The company operates 8 hospitals under the Paras Health brand across North India, Bihar, and Jharkhand.
The bed capacity stood at 2,135 beds as of March 31, 2024, up from 1,250 beds in March 2022.
The face value is ₹1 per equity share.
